Cancer Therapy
Integrated approach identifies genes that determine cancer cell chemosensitivity
Published in Clinical Oncology Week, May 30th, 2005
According to a recently published report from Japan, "We have established a panel of 45 human cancer cell lines (JFCR-45) to explore genes that determine the chemosensitivity of these cell lines to anticancer drugs.
"JFCR-45 comprises cancer cell lines derived from tumors of three different organs: breast, liver, and stomach. The inclusion of cell lines derived from gastric and hepatic cancers is a major point of novelty of this study."
"We determined the concentration of 53 anticancer drugs that could induce 50% growth inhibition...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Leukemia
Efficacy of combining fludarabine with cyclophosphamide and mitoxantrone tested - Liver Cancer
Predictive value of CLIP, Okuda, TNM and JIS staging systems evaluated - Lung Cancer
Sleeve resection resulted in higher locoregional recurrence of lung cancer - Pediatric Cancer
High incidence of malformation syndromes correlated to pediatric cancer - Prostate Cancer
High dose rate (HDR) brachytherapy treated localized prostate cancer - Abdominal Cancer
Internal and externals markers correlated with abdominal tumor motion - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
